Abstract:
A method for deriving optimal discriminating features indicative of a subject state when the subject listens to one of a set of musical pieces, comprising a step of extracting frequency features from the subject's EEG signal when the subject is in a first subject state and a second subject state, the frequency features being extracted from more than one frequency band in one set of time segments; and identifying optimal discriminating features from the extracted frequency features, the optimal discriminating features indicative of characteristics of the EEG signal when the subject is in the first subject state and the second subject state, wherein one of the first subject state and the second subject state indicates that the subject likes a musical piece while the other state indicates that the subject does not like the musical piece.
Abstract:
The present invention discloses a method of eliciting an immune response and a method of vaccination comprising administration of a mutated flavivirus. The mutated flavivirus comprises at least one mutation in a nucleic acid sequence encoding for the non-structural protein 5 of the flavivirus sequence resulting in inactivation of the 2′O-methyltransferase.
Abstract:
Antibodies of interest comprising a heavy chain signal peptide and/or a light chain signal peptide or combination thereof and compositions are described. The method of determining the signal peptide including creating data set of antibodies signal peptides, clustering, selecting and creating recombinant antibodies for enhanced expression and secretion are described.
Abstract:
There is provided an in vitro assay for screening a test compound for toxicity in renal proximal tubular cells. The method comprises contacting a test compound with a test population of renal proximal tubular cells; and examining one or more cell morphology features, examining one or more cytoskeleton features, and/or determining cell numbers of the renal proximal tubular cells in the test population and comparing such cell morphology, arrangement of cytoskeletal components and/or cell count with the respective features of a control population. A change in one or more cell morphology features, a change in arrangement of one or more cytoskeleton features or a decrease in cell numbers of the test population relative to the control population is indicative that the test compound is toxic for renal proximal tubular cells.
Abstract:
It is an object of the present invention to provide a catalyst that is excellent in stability even at a high catalyst-regeneration temperature. It is another object of the present invention to provide a process for producing an aromatic hydrocarbon from a lower hydrocarbon by using the above catalyst. The catalyst composition comprises molybdenum, a second metal that is not molybdenum, and a crystalline metallosilicate, wherein the content of molybdenum is 1 to 20% by weight in terms of a molybdenum atom, and the content of the second metal is 2 to 20% by weight in terms of a metal atom.
Abstract:
There is provided compound for use in therapy, the compound comprising repeating units of hydrophilic heterocyclic amine monomers that are coupled by hydrophobic linkers selected to confer a therapeutic effect. There is also provided the use of the above compound in the manufacture of a medicament for the treatment of a fungal infection and a method of treating a fungal infection using the above compound.
Abstract:
The invention provides method for imaging the activity of enzymes or bioactive molecules in cells using fluorescent probes with aggregation-induced emission properties and excited-state intramolecular proton transfer properties. The fluorescent probes prepared according to the invention are those of formula (I), wherein W, X, Y, Z have the meaning as described in the description, R is a reactive group that can interact with enzymes and other bioactive molecules, Linker is a single bond or a combination of chemical bonds linking the targeting group T to the probe molecule, and T represents a targeting group that has an ability to interact with an organelle.
Abstract:
A cognitive training method has a step of obtaining sensor data of a subject during a memory exercise which in turns determining whether the sensor data includes predetermined information indicative of cognitive functions used for remembering. The step of advancing the memory exercise is carried out when it is determined that the sensor data includes predetermined information indicative of cognitive functions used for remembering. The step of calculating an objective cognitive assessment of the subject when the memory exercise is completed and a cognitive training is measured at least partially in response to the advancing the memory exercise. The fact that an objective cognitive assessment is calculated provides a method of using an autodidactic cognitive training device.
Abstract:
A method of purifying a sample containing a desired protein includes the steps of (i) providing a packed chromatographic column having positively charged porous particles, (ii) equilibrating the column to the conditions to which the desired protein in the sample is to elute, (iii) contacting the sample with the packed chromatographic column such that the sample volume applied to the packed chromatographic column is less than or equal to the interparticle space of the positively charged porous particles within the packed chromatographic column, (iv) eluting the desired protein from the packed chromatographic column, where the desired protein is in a purer state and in the conditions to which the packed chromatographic column was equilibrated; where the desired protein is an antibody, an antibody fragment, an antibody derivative, or an antibody fusion protein.
Abstract:
A porous hollow silica particle with an interpolymer complex immobilized thereon is provided. The interpolymer complex comprises a first polymer immobilized to a surface of the silica particle, and a second polymer complexed with the first polymer. Pharmaceutical compositions comprising the silica particle, and methods of forming the silica particle are also provided.